418

Compound name
Pertuzumab
Alt Name
Perjeta
Omnitarg
Compound Image
Pertuzumab.png
Approval Jurisdiction
2012 FDA 2013 EMA
Approved for clinical use
HER2-Positive Breast Cancer
CAS
380610-27-5
Action
ERBB2
Approved Drug List
1
Commercial Vendor
Genentech